跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
Approved
STANDARD
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
BeiGene AUS Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
a5edfa4649bc0d59
Company
BeiGene AUS Pty Ltd
Type
Standard
Approval Details
Approval Id
a5edfa4649bc0d59
Product Name
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
Artg Id
391176
Artg Name
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
Sponsor
BeiGene AUS Pty Ltd
Company Detail Path
/organization/beigene-aus-pty-ltd
Artg Date
2024-05-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fcd45a4fae0f18678988e5d8e42754d2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5e28529f3ef2056a85e56ffb5fe74fdf.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
a5edfa4649bc0d59
Type
Standard
Back to TGA Approvals
